Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Nelnet, Inc.
20.4% sales growth and 6.72% return on equity
Nelnet, Inc. engages in loan servicing, communications, and education technology, services, and payment processing businesses worldwide.
Nelnet, Inc.'s sales growth this year is anticipated to be 44.5% and a negative 16.4% for next year.
Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 1.1B for the twelve trailing months.
Nelnet, Inc.'s sales growth for the next quarter is 20.4%. The company's growth estimates for the ongoing quarter and the next is 406.2% and 291.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.72%.
Volatility
Nelnet, Inc.'s last day, last week, and last month's average volatility was a negative 0.96%, a negative 0.26%, and a negative 0.09%, respectively.
Nelnet, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.40%, 1.80%, and 2.02%, respectively.
Nelnet, Inc.'s Stock Yearly Top and Bottom Value
Nelnet, Inc.'s stock is valued at $68.90 at 22:22 EST, below its 52-week high of $73.92 and way above its 52-week low of $36.70.
Nelnet, Inc.'s Moving Average
Nelnet, Inc.'s value is below its 50-day moving average of $69.69 and above its 200-day moving average of $62.78.2. Abbott Laboratories
24.2% sales growth and 10.57% return on equity
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide.
Abbott Laboratories's sales growth this year is expected to be 6.2% and 14% for next year.
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 32.22B for the twelve trailing months.
Abbott Laboratories's sales growth for the next quarter is 24.2%. The company's growth estimates for the current quarter and the next is 42.1% and 60%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.57%.
Volatility
Abbott Laboratories's last day, last week, and last month's average volatility was a positive 0.84%, a negative 0.08%, and a positive 0.03%, respectively.
Abbott Laboratories's last day, last week, and last month's high and low average amplitude percentage was 1.46%, 2.03%, and 1.69%, respectively.
Abbott Laboratories's Stock Yearly Top and Bottom Value
Abbott Laboratories's stock is valued at $107.79 at 22:22 EST, under its 52-week high of $115.14 and way above its 52-week low of $61.61.
Abbott Laboratories's Moving Average
Abbott Laboratories's worth is below its 50-day moving average of $108.86 and higher than its 200-day moving average of $103.41.3. Alamos Gold Inc Ordinary Shares
25.3% sales growth and 3.88% return on equity
Alamos Gold Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and extraction of gold deposits in North America.
Alamos Gold Inc Ordinary Shares's sales growth this year is expected to be 18.2% and 10.6% for next year.
Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 707.5M for the twelve trailing months.
Alamos Gold Inc Ordinary Shares's sales growth for the next quarter is 25.3%. The company's growth estimates for the present quarter and the next is 600% and 25%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.88%.
Volatility
Alamos Gold Inc Ordinary Shares's last day, last week, and last month's average volatility was a positive 0.57%, a negative 2.25%, and a positive 0.61%, respectively.
Alamos Gold Inc Ordinary Shares's last day, last week, and last month's high and low average amplitude percentage was 3.01%, 4.66%, and 3.92%, respectively.
Alamos Gold Inc Ordinary Shares's Stock Yearly Top and Bottom Value
Alamos Gold Inc Ordinary Shares's stock is valued at $8.68 at 22:22 EST, way below its 52-week high of $11.58 and way above its 52-week low of $3.34.
Alamos Gold Inc Ordinary Shares's Moving Average
Alamos Gold Inc Ordinary Shares's worth is below its 50-day moving average of $8.86 and under its 200-day moving average of $9.38.4. Capital Bancorp, Inc.
50.1% sales growth and 15.3% return on equity
Capital Bancorp, Inc. operates as the bank holding company for Capital Bank, N.A. that provides various commercial banking products and services to businesses, not-for-profit associations, and entrepreneurs in the United States.
Capital Bancorp, Inc.'s sales growth this year is expected to be 52.1% and 5.3% for next year.
Year-on-year quarterly revenue growth grew by 63.1%, now sitting on 115.18M for the twelve trailing months.
Capital Bancorp, Inc.'s sales growth for the next quarter is 50.1%. The company's growth estimates for the current quarter and the next is 52.8% and 85.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.3%.
Volatility
Capital Bancorp, Inc.'s last day, last week, and last month's average volatility was 0.29%, 0.37%, and 0.75%, respectively.
Capital Bancorp, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.15%, 3.17%, and 3.48%, respectively.
Capital Bancorp, Inc.'s Stock Yearly Top and Bottom Value
Capital Bancorp, Inc.'s stock is valued at $13.93 at 22:22 EST, below its 52-week high of $14.97 and way above its 52-week low of $6.98.